Preventiongenetics

Preventiongenetics company information, Employees & Contact Information

At PreventionGenetics, we are passionate about human genetics and its power to improve lives. Located in Marshfield, WI, PrevetionGenetics was founded in 2004 and acquired in 2022 by global cancer diagnostics leader, Exact Sciences. PreventionGenetics is a CLIA and ISO 15189:2012 accredited laboratory, delivering high-quality genetic testing at fair prices with exemplary service to patients, researchers and clinicians around the world. We provide tests for nearly all clinically relevant genes including our powerful and comprehensive whole-genome sequencing test, PGnome®, and whole-exome sequencing test, PGxome®. In the changing landscape of genetic testing, our quality and commitment to clinicians, researchers and patients remains unchanged. We stay on the forefront of clinical genetics and consistently expand and update our test menu, introduce new technologies and increase the efficiency of our processes. Content reflects information available and is accurate at the time of publication.

Company Details

Employees
173
Founded
-
Address
3800 South Business Park Avenue, Marshfield,wi 54449,united States
Phone
715-384-3661
Email
hr****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Marshfield, WI
Looking for a particular Preventiongenetics employee's phone or email?

Preventiongenetics Questions

News

Amyotrophic Lateral Sclerosis Genetic Access Program - Neurology® Journals

Amyotrophic Lateral Sclerosis Genetic Access Program Neurology® Journals

PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device - PR Newswire

PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device PR Newswire

PreventionGenetics Leaps Ahead With PGxome™ Custom Panels - PR Newswire

PreventionGenetics Leaps Ahead With PGxome™ Custom Panels PR Newswire

The RYR2-Encoded Ryanodine Receptor/Calcium Release Channel in Patients Diagnosed Previously With Either Catecholaminergic Polymorphic Ventricular Tachycardia or Genotype Negative, Exercise-Induced Long QT Syndrome: A Comprehensive Open - JACC Journals

The RYR2-Encoded Ryanodine Receptor/Calcium Release Channel in Patients Diagnosed Previously With Either Catecholaminergic Polymorphic Ventricular Tachycardia or Genotype Negative, Exercise-Induced Long QT Syndrome: A Comprehensive Open JACC Journals

Top Preventiongenetics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant